About Amit Rakhit, MD, MBA
Biotech Executive, Chief Medical Officer at BlueRock Therapeutics, Former CEO of Flare Therapeutics & Sporos Bioventures, Co-Founder of KoMocean
Amit Rakhit is a board-certified physician and biotech executive with over two decades of leadership spanning clinical development, global medical affairs, and executive strategy. From launching drugs at Biogen to leading companies like Ovid and Flare through transformative stages, Amit brings a mission-driven mindset to advancing science and access.
Executive Leadership in High-Impact Biotech
Amit Rakhit has served in executive roles across some of the most transformative biotech companies in the world. As CMO at BlueRock Therapeutics and former CEO of Flare Therapeutics and Sporos Bioventures, Amit has guided cross-functional teams in launching clinical assets and scaling organizations through IPO and beyond. His leadership is defined by science, strategy, and social mission.
From Clinic to Boardroom
Trained in pediatric cardiology at Harvard and educated at Columbia and London Business School, Amit combines deep clinical knowledge with high-level business insight. At Biogen, he led a global medical affairs organization of 800+ professionals. At Ovid, he shepherded rare disease therapies through clinical and commercial development. His cross-sector expertise makes him a trusted leader in modern medicine.
Amit Rakhit’s Story
Amit’s story began in California and advanced through the corridors of Tufts, Harvard, and global pharma. He has committed his life to improving patient outcomes, especially in underserved areas like rare diseases. As a co-founder of KoMocean and volunteer with The Trevor Project, he integrates identity and advocacy into executive leadership—fostering inclusion and purpose in every role he assumes.